BAMA BIOTECH, INC.
CIK 0001501804
Revenue (TTM)
—
Q3 Jul 2012
Net Income (TTM)
−$32.13K
Q3 Jul 2012
EPS Diluted (TTM)
—
Q3 Jul 2012
Gross Margin
—
Q3 Jul 2012
Operating Margin
—
Q3 Jul 2012
Net Margin
—
Q3 Jul 2012
Free Cash Flow (TTM)
—
Q3 Jul 2012
Cash
$0
Q3 Jul 2012
Total Debt
—
Q3 Jul 2012
Shares Outstanding
100K sh
Q3 Jul 2012